Debt-for-equity swap
Tikehau to become majority shareholder in Cruiseline
Following the deal, Montefiore retains a minority stake and a seat on the company's board
Bridgepoint-backed Fat Face in debt-to-equity swap – report
Deal would reduce Fat Face's present £120m borrowing levels via a debt-for-equity swap
Towerbrook to inject €100m in BC-backed CarTrawler in debt-for-equity swap
CarTrawler has €120m of its TLB and €25m of revolving credit facility debt outstanding
ICG transfers Esperi ownership to lenders
Esperi will be owned by a new parent company controlled by Danske Bank, Ilmarinen and SEB
EQT Credit moves in to take over Charterhouse's Bartec
EQT Credit II and EQT Credit Opportunities III have notified the Austrian regulator
Oaktree, KKR acquire Riverstone's Proserv via restructuring
Development comes three and a half years after Riverstone acquired the company for $750m
Lenders take control of CVC- and Eurazeo-backed Fraikin
Debt arranged as part of the 2007 LBO will be significantly reduced from €730m to €265m
Terra Firma to walk away from Four Seasons
Creditor H/2 Capital had originally proposed that the GP retain an 11% stake in the business
PE-backed Maxeda DIY in debt-for-equity refinancing
Second debt-for-equity reshuffle for retailer in five years
ICG to take over Courtepaille in debt-for-equity swap
ICG supplied €160m unitranche in 2010 Fondations Capital buyout
KKR's ATU in debt-for-equity swap
The creditors of KKR-backed car servicing chain Auto-Teile-Unger (ATU) have reduced the company's debt burden by €600m in exchange for equity.
Axa PE-backed Saur in debt-for-equity swap
Saur, a French water company backed by Axa Private Equity and sovereign wealth fund FSI, will be taken over by its lenders later this month.
Arle loses ETG in debt-for-equity swap
Arle Capital Partners' portfolio company EurotaxGlass (ETG) has been seized by its lenders, as an agreement on the reduction of its debt pile couldn't be reached.
Imperial Innovations in £17m round for Cell Medica
Imperial Innovations Group has invested in a £17m funding round for its portfolio company Cell Medica.